Evidence map›Paper›PMID 32572567›Full record

Observational studyHeart and vessels2020

Effect of nicorandil administration on cardiac burden and cardio-ankle vascular index after coronary intervention.

Shuji Sato, Mao Takahashi, Hiroshi Mikamo, Masayo Kawazoe, Takuo Iizuka, Kazuhiro Shimizu, Mahito Noro, Kohji Shirai

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Heart and vessels, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Observational
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Shuji SatoDepartment of Cardiology, Toho University Medical Center Sakura Hospital, 564-1 Shimoshizu, Sakura, Chiba, 285-8741, Japan. shuuji.satou@med.toho-u.ac.jp.ORCID http://orcid.org/0000-0002-6386-8670
Mao TakahashiDepartment of Cardiology, Toho University Medical Center Sakura Hospital, 564-1 Shimoshizu, Sakura, Chiba, 285-8741, Japan.
Hiroshi MikamoDepartment of Cardiology, Toho University Medical Center Sakura Hospital, 564-1 Shimoshizu, Sakura, Chiba, 285-8741, Japan.
Masayo KawazoeDepartment of Cardiology, Toho University Medical Center Sakura Hospital, 564-1 Shimoshizu, Sakura, Chiba, 285-8741, Japan.
Takuo IizukaDepartment of Cardiology, Toho University Medical Center Sakura Hospital, 564-1 Shimoshizu, Sakura, Chiba, 285-8741, Japan.
Kazuhiro ShimizuDepartment of Cardiology, Toho University Medical Center Sakura Hospital, 564-1 Shimoshizu, Sakura, Chiba, 285-8741, Japan.
Mahito NoroDepartment of Cardiology, Toho University Medical Center Sakura Hospital, 564-1 Shimoshizu, Sakura, Chiba, 285-8741, Japan.
Kohji ShiraiMihama Hospital, Chiba, Japan.
Toho University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myocardial injury is a problem associated with percutaneous coronary intervention (PCI). This study aimed to clarify the role of nicorandil administration in preventing myocardial injury. This study included patients with stable angina who underwent PCI from November 2013 to June 2016. Of 58 consecutive patients, the first 20 patients received only saline infusion after PCI (control group); the other 38 patients received a continuous intravenous infusion of nicorandil and saline after PCI (nicorandil group). Troponin I and brain natriuretic peptide (BNP) levels were measured. Vascular parameters, such as blood pressure (BP), cardiac output, cardio-ankle vascular index (CAVI), and estimated systemic vascular resistance (eSVR), were measured. Troponin I of both groups increased 12 h after PCI. Changes in BNP levels between immediately after PCI and 12 h after PCI were significantly higher in the control than in the nicorandil group (10.8 ± 44.2 vs. - 2.6 ± 14.6 pg/ml, p = 0.04). In the nicorandil group, BP, eSVR, and CAVI decreased significantly at 12 h after PCI compared with those immediately after PCI (p < 0.0001), whereas no change was observed in the control group. In a single linear analysis, the change in BP (r = 0.36, p < 0.01) and nicorandil administration (r = - 0.47, p < 0.001) was significantly correlated with the change in CAVI, multiple regression analysis revealed that the changes in CO and eSVR were significant contributing factors for the changes in CAVI. PCI could result in myocardial injury and/or cardiac burden in patients with stable angina. Nicorandil administration after PCI may be effective in relieving the burden by decreasing arterial stiffness (CAVI).

Indexed as

AgedAngina, StableCoronary Artery DiseaseFemaleHeart DiseasesHemodynamicsHumansInfusions, IntravenousMaleMiddle AgedNicorandilPercutaneous Coronary InterventionTime FactorsTreatment OutcomeVascular StiffnessVasodilator AgentsNicorandilVasodilator AgentsAnginaCardiac burdenCardio-ankle vascular indexMyocardial injuryNicorandilPercutaneous coronary intervention

Identifiers

PMID32572567
PMCPMC7595970
OpenAlexW3036780937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.